Kayaalt, Z. Et Al. 2015. Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution?. 51st Congress of the European-Societies-of-Toxicology (EUROTOX) , (Porto, Portugal).

Kayaalt, Z., Kaya-Akyuzu, D., Ozdemir, F., Soylemez-Gokyer, D., Kara, B. A., & Soylemezoglu, T., (2015). Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution? . 51st Congress of the European-Societies-of-Toxicology (EUROTOX), Porto, Portugal

Kayaalt, Z. Et Al. "Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution?," 51st Congress of the European-Societies-of-Toxicology (EUROTOX), Porto, Portugal, 2015

Kayaalt, Z. Et Al. "Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution?." 51st Congress of the European-Societies-of-Toxicology (EUROTOX) , Porto, Portugal, 2015

Kayaalt, Z. Et Al. (2015) . "Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution?." 51st Congress of the European-Societies-of-Toxicology (EUROTOX) , Porto, Portugal.

@conferencepaper{conferencepaper, author={Z. Kayaalt Et Al. }, title={Is there a difference between the thalassemia patient and control group in GSTO1 and GSTO2 genotype distribution?}, congress name={51st Congress of the European-Societies-of-Toxicology (EUROTOX)}, city={Porto}, country={Portugal}, year={2015}}